TruBridge Q4 2025 Earnings Call Insights
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Should l Buy TBRG?
Source: seekingalpha
- Financial Results Overview: TruBridge reported Q4 revenue of $87.2 million and adjusted EBITDA of $19.2 million, with revenue down approximately 1% year-over-year, yet an adjusted EBITDA margin of 22% indicates some improvement in profitability.
- Strategic Review Progress: CEO Fowler emphasized that the company is undergoing a strategic review, expecting modest revenue growth in 2026 and approximately 200 basis points of adjusted EBITDA margin improvement, although no formal financial guidance was provided.
- Sales Pipeline Performance: TruBridge's overall sales pipeline value is at its highest in nine quarters, increasing by 53% since Q3, indicating enhanced commercial momentum, particularly through strategic partnerships with Microsoft and the Dragon Copilot integration.
- Audit Adjustment Impact: The company identified significant noncash misstatements during the audit process, leading to revisions of prior financial statements; while these adjustments are deemed non-material to the fiscal 2025 financials, they highlight the need for strengthened financial reporting and control processes.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TBRG?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TBRG
Wall Street analysts forecast TBRG stock price to rise
2 Analyst Rating
0 Buy
2 Hold
0 Sell
Hold
Current: 14.000
Low
21.00
Averages
22.00
High
23.00
Current: 14.000
Low
21.00
Averages
22.00
High
23.00
About TBRG
TruBridge, Inc. is a provider of healthcare solutions and services for community hospitals, their clinics and other healthcare systems. The Company’s segments are Financial Health and Patient Care. The Financial Health reporting segment focuses on providing a complete revenue cycle management (RCM) solution for all care settings, regardless of their primary healthcare information solutions provider, along with business management, consulting, managed IT services, analytics, and business intelligence. The Patient Care segment provides comprehensive acute care solutions and related services for community hospitals and their physician clinics. The Patient Care segment also offers comprehensive patient engagement and empowerment technology solutions to improve patient outcomes and engagement strategies with care providers. Its HFMA Peer Reviewed suite of RCM offerings combines visibility and transparency to enhance productivity and support the financial health of healthcare organizations.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Financial Results Overview: TruBridge reported Q4 revenue of $87.2 million and adjusted EBITDA of $19.2 million, with revenue down approximately 1% year-over-year, yet an adjusted EBITDA margin of 22% indicates some improvement in profitability.
- Strategic Review Progress: CEO Fowler emphasized that the company is undergoing a strategic review, expecting modest revenue growth in 2026 and approximately 200 basis points of adjusted EBITDA margin improvement, although no formal financial guidance was provided.
- Sales Pipeline Performance: TruBridge's overall sales pipeline value is at its highest in nine quarters, increasing by 53% since Q3, indicating enhanced commercial momentum, particularly through strategic partnerships with Microsoft and the Dragon Copilot integration.
- Audit Adjustment Impact: The company identified significant noncash misstatements during the audit process, leading to revisions of prior financial statements; while these adjustments are deemed non-material to the fiscal 2025 financials, they highlight the need for strengthened financial reporting and control processes.
See More
- Delayed Financial Reporting: On March 16, 2026, TruBridge announced it would not timely file its 2025 Annual Report due to identified errors in its 2024 consolidated financial statements, which could undermine investor confidence and lead to stock price volatility.
- Stock Price Decline: Following the announcement, TruBridge's shares fell by $1.84, or approximately 10.5%, from $17.59 to close at $15.75, reflecting market concerns over the company's financial transparency.
- Error Analysis: The company indicated that the majority of errors pertained to revenue accounting, software development costs, and share-based payments, which may prompt further scrutiny from regulators and increase legal risks.
- Ongoing Legal Investigation: No lawsuits have been filed yet, but Kirby McInerney LLP is investigating potential violations of federal securities laws by TruBridge and its senior management, and adverse findings could lead to more claims from investors.
See More
- Financial Overview: Computer Programs and Systems reported a Q4 GAAP EPS of -$0.37, with total revenue reaching $87.2 million, indicating potential for revenue growth despite the loss.
- Financial Health Revenue Growth: Financial Health revenue increased to $56.2 million from $55.0 million year-over-year, representing 65% of total revenue, highlighting the company's ongoing development in this segment.
- Annual Performance Comparison: For FY2025, total revenue was $346.8 million, up from $342.2 million in FY2024, reflecting the company's stability and growth capacity in the market.
- Significant Non-GAAP Net Income Increase: Non-GAAP net income surged to $11.4 million compared to $1.1 million last year, demonstrating improvements in operational efficiency and profitability.
See More
- Earnings Release Schedule: TruBridge, Inc. has announced that it will release its financial results for the fourth quarter and year ended December 31, 2025, on March 31, 2026, demonstrating the company's commitment to transparency.
- Postponement Context: The company announced on March 16, 2026, that it would postpone its original earnings release date and related earnings call to allow additional time for year-end audit procedures, reflecting a cautious approach to audit compliance.
- Conference Call Details: The company will host a conference call at 3:30 p.m. Central Time (4:30 p.m. Eastern Time) on March 31, 2026, with investors able to dial (877) 407-0890 to participate, enhancing investor engagement.
- Live Broadcast and Replay: TruBridge's conference call will be available via live broadcast on the company's investor relations website, with a 30-day online replay accessible approximately one hour after the live event, ensuring timely information access for investors.
See More
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ:TBRG) due to allegations of issuing materially misleading business information, indicating possible investor losses.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, stating its inability to file its Annual Report for the fiscal year ended December 31, 2025, due to identified errors in previously issued financial statements, which may impact investor confidence.
- Stock Price Decline: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and reliability.
- Class Action Preparation: Rosen Law Firm is preparing a class action seeking recovery for investors without any out-of-pocket fees, highlighting the importance of legal support for investor rights and the potential for compensation amidst financial discrepancies.
See More
- Securities Claims Investigation: Rosen Law Firm is investigating potential securities claims against TruBridge, Inc. (NASDAQ: TBRG) due to allegations of issuing materially misleading business information, highlighting significant risks in the company's information disclosure practices.
- Delayed Financial Reporting: On March 17, 2026, TruBridge filed a Notification of Late Filing on Form 12b-25, indicating its inability to file the Annual Report for the fiscal year 2025 due to the identification of errors in previously issued financial statements, which may undermine investor confidence in the company's financial health.
- Stock Price Impact: Following this news, TruBridge's stock price fell by $1.84, or 10.5%, closing at $15.75 per share, reflecting market concerns regarding the company's financial transparency and management capabilities.
- Class Action Preparation: Rosen Law Firm is preparing a class action lawsuit, allowing investors to seek compensation without any out-of-pocket costs, indicating that the company may face broader financial liabilities due to legal risks.
See More










